Skip to content

Kura Oncology KURA Revenue from contracts outside the scope of ASC Topic 606

Revenue from contracts outside the scope of ASC Topic 606 at other companies

Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$0-100%
Harley-Davidson logo
Harley-DavidsonHOG
$111.94M-54.3%
General Motors logo
General MotorsGM
$4.28B+2.8%
Green Dot logo
Green DotGDOT
$27.24M+26.0%
Intuitive Machines, Inc. logo
Intuitive Machines, Inc.LUNR
$3.1M
Madison Square Garden Entertainment logo
Madison Square Garden EntertainmentMSGE
$9.01M+6.2%

Segments

By product

See full
Development Services For Monotherapy$28M+5,500%
Development Services In Combination With Other Therapies$19.3M+2,313%

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$919.7M+81.6%
Enterprise value$904.89M+90.7%
P/S12.8×+3.5×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×